(secondQuint)Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions.

 Study Type: Interventional Study Design: Randomized, 2-period, 2-sequence, crossover design.

 Official Title: Randomized, 2-Way Crossover, Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions.

 Further study details as provided by Actavis Elizabeth LLC: Primary Outcome Measures: Rate and Extend of Absorption.

 Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions@highlight

The objective of this study was to compare the rate and extent of absorption of Purepac, a subsidiary of Alpharma Inc.

, U.

S.

A.

, galantamine and Janssen Pharmaceutica Products, L.

P.

, U.

S.

A.

 (Reminyl),galantamine, administered as a 1 x 4 mg tablet, under fed conditions.

